交易中 05-19 11:27:15 美东时间
0.000
0.00%
UBS analyst Vilas Abraham maintains Hercules Capital (NYSE:HTGC) with a Neutral and raises the price target from $15 to $15.5.
今天 03:27
Hercules Capital, Inc. received a Hold rating and a $15.50 price target from UB...
05-18 21:37
Viridian Therapeutics (VRDN) priced upsized concurrent public offerings totaling $350M in gross proceeds, including $225M of 1.75% convertible senior notes due 2032 and $125M of common stock. The conv...
05-07 13:36
Viridian prices USD 225 million 1.75% convertible senior notes due 2032 Viridian priced USD 225 million of 1.75% convertible senior notes due 2032 in an upsized public offering. Net proceeds from debt offering, combined with concurrent equity sale, expected at about USD 334.7 million. Interest payab
05-07 11:17
Viridian prices upsized USD 225 million 1.75% convertible senior notes due 2032 Viridian Therapeutics priced USD 225 million of 1.75% convertible senior notes due 2032 in an upsized underwritten public offering. Deal expected to close May 11, 2026. Initial conversion rate set at 40.5680 shares per U
05-07 11:13
Earnings Call Insights: Hercules Capital (HTGC) Q1 2026 Management View "In the first quarter of 2026, Hercules delivered another strong quarter of record originations, record total investment income ...
05-06 11:23
Hercules Capital, Inc. ( ($HTGC) ) just unveiled an announcement. On April 30, ...
05-06 06:39
Hercules Capital press release (HTGC): Q1 NII of $0.48 beats by $0.02. Total investment income of $141.5M (+18.4% Y/Y) in-line. More on Hercules Capital Hercules Capital: Big Commitments, Big Premium ...
05-06 05:23
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
An announcement from Hercules Capital, Inc. ( ($HTGC) ) is now available. On Ap...
05-05 05:47